Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Apparently this is a show-me-the-money market. Despite what looks like very promising trial results, the PPS goes nowhere. No point complaining, it is what it.
We won't see the money in the PPS until the market sees the announcement that PPHM has a big money deal of some kind with somebody. I guess that's fair.
Paul
The mounting evidence that Bavi is safe and effective will hit critical mass someday, apparently not today. Too bad.
Fortunately, there may be much more good news in the next few months.
Waiting for this train to leave the station is not so hard when the news continues to be this good.
Paul
Who buys and sells this stock? Almost nobody. Less than one-half of one percent of the outstanding share sell on a big day. So, the holders of this stock are just sitting on their holdings and waiting to find out whether they are sitting on a gold mine or a dung heap.
Who owns this stock? My guess is they're mostly like me. I own a few 10s of thousands of shares. I consider PPHM a speculation, not too much different from a lottery ticket.
Who controls the daily price moves of PPHM? A few dozen day traders who are making and losing money at each others expense.
When will it end? When PPHM soars or crashes. As has been said before on this board, our conclusion should be soon.
All IMHO - Paul
This Rodney Dangerfield act is really getting old. However, BAVI AC seems to be marching along splendidly. Despite the sniping from R and R, PPHM is looking stronger than ever. Let's hope the day is coming soon, when PPHM no longer returns R and R's phone calls.
Paul
I agree, send it to PPHM. I don't see that continuing our relationship with those base turds makes any sense.
Does anyone know how many weeks after the first group was dosed in Georgia that we got a report on how well they were doing?
Thanks,
Paul
If the PPS is being played, who is the player and what is the song? It's OK with me if the song is "Happy Days Are Here Again".
Paul
Anyone who would question this well known "quote" clearly knows nothing about Peregrine and should not post on topics of which they know nothing.
Paul
Moderators, please consider turning on the ignore feature for all board users. Todays posters should not be afforded unlimited ability to publish their screeds.
Thanks,
Paul
Are you suggesting the someone/some thing is buying on any dips, because they are expecting a significant near term move up in the PPS?
Paul
Second day in a row that the PPS has spiked at the close. Not a big spike, but a spike. Is this happenstance, or does it actually mean something profound regarding future price movements?
Paul
BOT, thanks for your contribution. I hope your hearing is 20/20.
HNY,
Paul
Whether PPHM has the leanest operation or not will not materially affect the outcome for the company. Many of us who have invested considerable sums in PPHM do not have the patience to engage in discussions that are too far removed from the real issue.
The real issue is whether Bavi represents a medical advance that will help thousands of people and generate a handsome return to PPHM investors/speculators.
Paul
Isn't interesting that they are focusing on the envelope of the HIV? Let's hope our little enveloped virus MAB can contribute to this effort. When will we hear anything from the HEPC/HIV trial? It would seem to be a smorgasbord for BAVI.
Paul
There are far too few eyes on PPHM. Like all longs, I hope that situation will change when/if the Georgia and India trials solidify Bavi's position as a significant new treatment option for cancer.
Paul
I'm sure it's been said before, but if PPHM does not break out to the upside in the next six months, it never will. All eyes are on Georgia and India.
The anti-viral Bavi application is exciting, but Bavi anti-cancer is much closer to the finish line. Continuing Phase II success might just trigger a buyout.
Does anyone think that PPHM can make a go of it on Bavi anti-viral alone? Of course, if the HepC-HIV trial finally does come through with blowout numbers, this may change the situation.
I'm biting my nails waiting for the next Phase II report.
Paul
Speculation, not fantasy. Anyone who has held PPHM stock for more than few years should understand this propositon. PPHM may come to nothing or sell for multiple billions in the next year or two.
We do know for sure that what the stock did in 2008 is irrelevant to what it may do in 2009.
Paul
Obviously the stock price went in reverse this year. Shall we spend some time discussing the obvious? Management doesn't buy shares in PPHM. Also not new. Shall we rehash this point a few more times.
Old news contributes nothing to this board of PPHM followers. Those of you who can stop looking in the rear view mirror might see something more interesting.
I predict PPHM will be bought out this year for 1.2 billion dollars. Furthermore, the purchaser will recoup their full investment in 6 mos. Everyone who now owns PPHM will live happily ever after.
Happy NEW Year!
Paul
Merry Christmas to all, especially to those who fretted endlessly about a reverse split and catastrophic dilution that never happened. It was possible, but obsessing about it was not fun to read and as it turns out was utterly wrong. HO,HO, HO.
Paul
The first NSCLC patient in India was apparently dosed on or about July 1st, almost 5 months ago. Is there any reason to believe these results will be better or worse than the Georgia breast cancer results?
Paul
Nine weeks have past since the announcement on October 20, my birthday, of completed enrollment of the first cohort of NSCLC patients in India. When should be hear something?
Paul
As we once again enter a negative PPS phase, it is time for encouraging words from BOT. As his contributions are unfailingly optimistic and reasonably accurate, it is about time for another posting.
Paul
With all due respect, the moving averages on a stock like PPHM don't mean much to longs IMHO. We are looking at the trees, not the forrest. If the trees are healthy, someday we'll have the sort of forrest that merits technical analytical tools.
Is Avid generating more profits?
Is the burn rate getting better?
Can management continue to fund operations without significant dilution?
Are the clinical trials yielding good results?
Is there more in the anti-PS pipeline?
Is the DTRA happy with our contract?
Will the Esptein law suit yield data/money?
Will the long awaited Duke publication(s) impress the hell out of potential partners or buyers?
Are the clinical trials yielding good results? (Repeated for emphasis).
These are the questions that interest me and the rest of us who own the 99.85% of the stock not sold today.
Paul
In view of the poison pill, how much would a motivated buyer have to pay for PPHM?
Any ideas?
Paul
What happened to the volume? Nobody buying, nobody selling.
What does is it portend?
Paul
So, the winner is clearwater2. I wondered who would be the first poster to start singing the RS song. Congratulations.
The RS was a scary prospect for a company that looked like it would run out of cash before it completed critical Phase II testing. With the infusion of government grant, Avid profit and commercial loans funds, it now appears IMHO that PPHM will be able to complete the Phase II tests.
The RS is only a delisting issue, not a dilution issue. The only issue that now matters is the Phase II testing. If it pans out, we are home free. If it doesn't, we're probably screwed unless Uncle Sugar decides he needs a few hundred million dollars of Bavi in his medicine chest.
So, the discussion of RS and near term dilution it dead except for the usual suspects. We all know who they are. As they are ignored by most of us, they can continue to enjoy talking to each other.
Season Greetings,
Paul
I was wrong. We didnt't get a clinical trials update today. However, we did get non-dilutive financing through 2009. I think we all breathed a sigh of relief over that.
If that 71% response figure in the anti-cancer trials continues and is replicated in the other trials, I'd like to think it will attract a moneyed partner/buyer.
With this successful financing, I think the much maligned PPHM management has earned a little respect or at least silence from the usual suspects.
Paul
I predict we will have a PR tomorrow updating results from one of the Phase II trials. It seems these updates happily coincide with quarterly conference calls.
However good the data, if we don't hear something on the financing side, I hate to think what will happen to the share price.
Ever the optimist,
Paul
All stockholders anxiously await hearing how PPHM plans to fund its activities. However, I don't know why any investor in PPHM would think its management would hire or retain unnecessary employees when it is facing an critical cash crunch.
Are there actually people who post on this thread just to insult the common sense of company management and by extension those who invest in such a company?
Amazing.
Paul
CJ,
Any chance this presentation will be webcast?
Also, does this bring 2C3 any closer to a partnering deal? Or does it have to go to the clinic in your opinion?
Thanks,
Paul
Is this recent up move a day trader play or is the kind of move that will last? I sincerely hope it is the latter.
Paul
An observation and a question.
First the observation: It's hard to get too enthusiastic at $.28 per share, but I have to point out that recently PPHM's SP has gone up and stayed up on good news. This is different.
We can only hope that this is the beginning of the long overdue upside move.
The question: Is lung cancer a good target for Bavi? I seem to recall some posters suggesting that Bavi might need an inhalable delivery method to be effective in the lung.
Paul
I found it interesting that the recently approved patent was submitted in 2003. It took five years to approve. I don't know if that speaks to the importance of the patent or the backlog at the patent office.
As I scanned through the patent, I was amazed at how optimistic Thorpe et all were regarding the anti-cancer prospects for their invention. They were very sure in 2003 that it would be a major force in cancer treatment.
Those of us who read the patent application in 2003 and were motivated to buy PPHM shares certainly have waited a long time for our return. I hope that return is coming soon.
Paul
If Bavi proves a useful therapy both as an anti-cancer and as and anti-viral treatment, which potential buyer would be most likely?
How much might PPHM be worth?
Could the sale price realistically exceed the poison pill price of around $11 per share?
If it does sell for over the PP price, where should we hold the party?
Sorry to be a pumper, but to avoid violating the equal time provisions, I thought someone should present an optimistic viewpoint on PPHM's prospects.
Paul
What's so interesting?
Can you get past the abstract to the entire article without buying a subscription?
Paul
Well put Westie. It would OK if Christmas comes early this year.
Paul
Geocappy, he doesn't sound like a salesman. However, I don't think his job is to sell the retail investors. His job, as I see it, is to sell PPHM to a BP with more money than pipeline. If he can do that, I won't be bored.
Paul
Thanks for posting the synopsis and the link. This rubber band is really stretched out. Will it break or will it propel us to profitablility?
Paul
A close reading of the release clearly says they are not adding new reactors, they are retrofitting the existing reactors in a way that significantly increases capacity at a controlled cost. Sounds like a good business decision.
The capacity increase must be substantial. Otherwise why make this announcement? For those of limited education, this is a rhetorical question. It is not meant to be an opening to be filled by the usual suspects with their usual line of anti-PPHM-propaganda.
Sometimes a cigar is just a cigar.
Paul
Apparently, the AVID employees haven't been reading this board. They don't know that they are going under. Poor deluded suckers, almost as dumb as us longs.
Humor aside, this does provide another hint that PPHM may do more than just survive. It may even flourish. I am prepared to be amazed.
Paul